CorMedix (CRMD) Total Current Liabilities (2010 - 2025)

CorMedix has disclosed Total Current Liabilities across 15 years of filings, most recently posting $174.3 million for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $174.3 million, up 414.98% year-over-year; the trailing twelve-month figure through Dec 2025 was $174.3 million (up 414.98% YoY), and the FY2025 annual result was $174.3 million, up 414.98% from the prior year.
• Total Current Liabilities came in at $174.3 million for Q4 2025 at CorMedix, up from $133.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $174.3 million in Q4 2025 to a low of $3.0 million in Q1 2021.
• The 5-year median for Total Current Liabilities is $7.5 million (2023), against an average of $25.8 million.
• Across the five-year window, Total Current Liabilities slumped 47.46% in 2021 and soared 623.14% in 2025, its largest moves.
• CorMedix's Total Current Liabilities stood at $5.3 million in 2021, then grew by 18.07% to $6.3 million in 2022, then surged by 80.65% to $11.4 million in 2023, then jumped by 196.83% to $33.8 million in 2024, then soared by 414.98% to $174.3 million in 2025.
• The last three Total Current Liabilities figures came in at $174.3 million (Q4 2025), $133.6 million (Q3 2025), and $31.7 million (Q2 2025), per Business Quant data.